en
Scientific article
English

Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke

Published inBiomarker insights, vol. 2, p. 155-164
Publication date2007
Abstract

Efficacy of thrombolysis in acute ischemic stroke is strongly related to physician's ability to make an accurate diagnosis and to intervene within 3-6 h after event onset. In this context, the discovery and validation of very early blood markers have recently become an urgent, yet unmet, goal of stroke research. Ubiquitin fusion degradation protein 1 is increased in human postmortem CSF, a model of global brain insult, suggesting that its measurement in blood may prove useful as a biomarker of stroke.

Citation (ISO format)
ALLARD, Laure et al. Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. In: Biomarker insights, 2007, vol. 2, p. 155–164.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1177-2719
549views
0downloads

Technical informations

Creation11/15/2013 11:25:00 AM
First validation11/15/2013 11:25:00 AM
Update time03/14/2023 8:52:41 PM
Status update03/14/2023 8:52:41 PM
Last indexation01/16/2024 8:58:32 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack